Bright Minds Biosciences Inc. - stock earnings
DRUG Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.3 million USD | ? USD |
| 2023Q3 | -1.1 million USD | ? USD |
| 2023Q2 | -1.1 million USD | ? USD |
| 2023Q1 | -1.6 million USD | ? USD |
| 2022Q4 | -1.8 million USD | ? USD |
| 2022Q3 | -2.1 million USD | ? USD |
| 2022Q2 | -2.1 million USD | ? USD |
| 2022Q1 | -3.7 million USD | ? USD |
| 2021Q4 | -3.8 million USD | ? USD |
| 2021Q3 | -2.3 million USD | ? USD |
| 2021Q2 | -2.9 million USD | ? USD |
| 2021Q1 | -1.3 million USD | ? USD |
| 2020Q4 | -591840 USD | ? USD |
| 2020Q3 | -302523 USD | ? USD |
| 2020Q2 | -29618 USD | ? USD |
| 2020Q1 | -4332 USD | ? USD |
| 2019Q4 | -24051 USD | ? USD |
DRUG Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.4 million USD | ? USD |
| 2022 | -11.1 million USD | ? USD |
| 2021 | -6.7 million USD | ? USD |
| 2020 | -365136 USD | ? USD |
| 2019 | -59711 USD | ? USD |
DRUG
Price: $1.05
52 week price:
Earnings Per Share: -1.21 USD
P/E Ratio: -1.30
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 141500
Market Capitalization: 5.8 million